Per‐Ove Sjöquist
About
Per‐Ove Sjöquist is a scholar working on Pathology and Forensic Medicine, Cardiology and Cardiovascular Medicine and Molecular Biology.
According to data from OpenAlex, Per‐Ove Sjöquist has authored 64 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pathology and Forensic Medicine, 26 papers in Cardiology and Cardiovascular Medicine and 18 papers in Molecular Biology. Recurrent topics in Per‐Ove Sjöquist's work include Cardiac Ischemia and Reperfusion (29 papers), Cardiac electrophysiology and arrhythmias (18 papers) and Nitric Oxide and Endothelin Effects (14 papers). Per‐Ove Sjöquist is often cited by papers focused on Cardiac Ischemia and Reperfusion (29 papers), Cardiac electrophysiology and arrhythmias (18 papers) and Nitric Oxide and Endothelin Effects (14 papers). Per‐Ove Sjöquist collaborates with scholars based in Sweden, United States and Romania. Per‐Ove Sjöquist's co-authors include John Pernow, Lars Rydén, Adrian Gonon, Qing‐Dong Wang, Jon O. Lundberg, Hari Shanker Sharma, Aliaksandr Bulhak, Syed F. Ali, Jiangning Yang and Andrey Gourine and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of the American College of Cardiology and PLoS ONE.
In The Last Decade
Per‐Ove Sjöquist
64 papers receiving 1.6k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Per‐Ove Sjöquist Sweden | 24 | 576 | 468 | 401 | 397 | 192 | 64 | 1.6k | ||
| Zoltán Szilvássy Hungary | 27 | 497 0.9× | 734 1.6× | 594 1.5× | 661 1.7× | 252 1.3× | 155 | 2.2k | ||
| Barbara Huisamen South Africa | 25 | 451 0.8× | 410 0.9× | 722 1.8× | 289 0.7× | 148 0.8× | 74 | 1.7k | ||
| David M. Ansley Canada | 23 | 390 0.7× | 649 1.4× | 387 1.0× | 226 0.6× | 343 1.8× | 42 | 1.6k | ||
| Abdullah Tuncay Demiryürek Türkiye | 22 | 208 0.4× | 350 0.7× | 508 1.3× | 479 1.2× | 234 1.2× | 140 | 1.9k | ||
| Akiyoshi Hara Japan | 16 | 471 0.8× | 359 0.8× | 405 1.0× | 276 0.7× | 115 0.6× | 50 | 1.4k | ||
| Han‐Wu Deng China | 25 | 279 0.5× | 271 0.6× | 523 1.3× | 431 1.1× | 188 1.0× | 68 | 1.6k | ||
| Reza Badalzadeh Iran | 24 | 255 0.4× | 441 0.9× | 532 1.3× | 233 0.6× | 109 0.6× | 92 | 1.4k | ||
| Cherry L. Wainwright United Kingdom | 24 | 653 1.1× | 385 0.8× | 474 1.2× | 363 0.9× | 213 1.1× | 93 | 1.6k | ||
| Paul M. Kerr Canada | 15 | 343 0.6× | 506 1.1× | 1.2k 3.0× | 380 1.0× | 168 0.9× | 27 | 1.9k | ||
| Keisuke Satoh Japan | 26 | 439 0.8× | 380 0.8× | 521 1.3× | 367 0.9× | 233 1.2× | 116 | 1.6k |
Countries citing papers authored by Per‐Ove Sjöquist
Since
Specialization
Citations
This map shows the geographic impact of Per‐Ove Sjöquist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per‐Ove Sjöquist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per‐Ove Sjöquist more than expected).
Fields of papers citing papers by Per‐Ove Sjöquist
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Per‐Ove Sjöquist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per‐Ove Sjöquist. The network helps show where Per‐Ove Sjöquist may publish in the future.
Co-authorship network of co-authors of Per‐Ove Sjöquist
This figure shows the co-authorship network connecting the top 25 collaborators of Per‐Ove Sjöquist. A scholar is included among the top collaborators of Per‐Ove Sjöquist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per‐Ove Sjöquist. Per‐Ove Sjöquist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sharma, Hari Shanker, José Vicente Lafuente, Dafin F. Mureșanu, et al.. (2021). REMOVED: Methamphetamine exacerbates pathophysiology of traumatic brain injury at high altitude. Neuroprotective effects of nanodelivery of a potent antioxidant compound H-290/51. Progress in brain research. 266. 123–124.
2.
Sharma, Hari Shanker, José Vicente Lafuente, Dafin F. Mureșanu, et al.. (2021). Neuroprotective effects of insulin like growth factor-1 on engineered metal nanoparticles Ag, Cu and Al induced blood-brain barrier breakdown, edema formation, oxidative stress, upregulation of neuronal nitric oxide synthase and brain pathology. Progress in brain research. 266. 97–121.
3.
Mureșanu, Dafin F., Aruna Sharma, Z. Ryan Tian, et al.. (2020). REMOVED: Diabetes exacerbates brain pathology following a focal blast brain injury: New role of a multimodal drug cerebrolysin and nanomedicine. Progress in brain research. 258. 285–286.
4.
Gonon, Adrian, Christian Jung, Abram Katz, et al.. (2012). Local Arginase Inhibition during Early Reperfusion Mediates Cardioprotection via Increased Nitric Oxide Production. PLoS ONE. 7(7). e42038–e42038.
5.
Sharma, Hari Shanker, Syed F. Ali, Z. Ryan Tian, et al.. (2009). Chronic Treatment with Nanoparticles Exacerbate Hyperthermia Induced Blood-Brain Barrier Breakdown, Cognitive Dysfunction and Brain Pathology in the Rat. Neuroprotective Effects of Nanowired-Antioxidant Compound H-290/51. Journal of Nanoscience and Nanotechnology. 9(8). 5073–5090.
6.
Sharma, Hari Shanker, et al.. (2009). A New Antioxidant Compound H-290/51 Attenuates Nanoparticle Induced Neurotoxicity and Enhances Neurorepair in Hyperthermia. Acta neurochirurgica. Supplementum. 106. 351–357.
7.
Sharma, Hari Shanker, Per‐Ove Sjöquist, & Syed F. Ali. (2007). Drugs of Abuse-Induced Hyperthermia, Blood-Brain Barrier Dysfunction and Neurotoxicity: Neuroprotective Effects of a New Antioxidant Compound H-290/51. Current Pharmaceutical Design. 13(18). 1903–1923.
8.
Bulhak, Aliaksandr, Joy Roy, Ulf Hedin, Per‐Ove Sjöquist, & John Pernow. (2007). Cardioprotective effect of rosuvastatin in vivo is dependent on inhibition of geranylgeranyl pyrophosphate and altered RhoA membrane translocation. American Journal of Physiology-Heart and Circulatory Physiology. 292(6). H3158–H3163.
9.
Molosh, Andrei I., et al.. (2005). Endothelin‐1 exerts a preconditioning‐like cardioprotective effect against ischaemia/reperfusion injury via the ETA receptor and the mitochondrial KATP channel in the rat in vivo. British Journal of Pharmacology. 144(3). 331–337.
10.
Nordlander, Margareta, Per‐Ove Sjöquist, Hans Ericsson, & Lars Rydén. (2004). Pharmacodynamic, Pharmacokinetic and Clinical Effects of Clevidipine, an Ultrashort‐Acting Calcium Antagonist for Rapid Blood Pressure Control. Cardiovascular Drug Reviews. 22(3). 227–250.
11.
Wang, Qing‐Dong, Daisuke Segawa, Hans Ericsson, et al.. (2002). Time-dependent Cardioprotection With Calcium Antagonism and Experimental Studies With Clevidipine in Ischemic-reperfused Pig Hearts: Part I. Journal of Cardiovascular Pharmacology. 40(2). 228–234.
12.
Segawa, Daisuke, Per‐Ove Sjöquist, Qing‐Dong Wang, Adrian Gonon, & Lars Rydén. (2002). Time-dependent Cardioprotection With Calcium Antagonism and Experimental Studies With Clevidipine in Ischemic-reperfused Pig Hearts: Part II. Journal of Cardiovascular Pharmacology. 40(3). 339–345.
13.
Gourine, Andrey, et al.. (2002). Calcium Antagonist Clevidipine Reduces Myocardial Reperfusion Injury by a Mechanism Related to Bradykinin and Nitric Oxide. Journal of Cardiovascular Pharmacology. 40(4). 564–570.
14.
Shimizu, Masafumi, Qing‐Dong Wang, Per‐Ove Sjöquist, & Lars Rydén. (1999). The Angiotensin II AT1 Receptor Antagonist Candesartan at Antihypertensive Plasma Concentrations Reduces Damage Induced by Ischemia–Reperfusion. Cardiovascular Drugs and Therapy. 13(4). 347–354.
15.
Shimizu, Masafumi, Qing‐Dong Wang, Per‐Ove Sjöquist, & Lars Rydén. (1999). Combination of a Calcium Antagonist, a Lipid-Peroxidation Inhibitor, and an Angiotensin AT1-Receptor Antagonist Provides Additive Myocardial Infarct Size-Limiting Effect in Pigs. Journal of Cardiovascular Pharmacology. 34(4). 512–517.
16.
Nagy, András, et al.. (1996). Effects of a novel low-molecular weight antioxidant on cardiac injury induced by hydrogen peroxide. Free Radical Biology and Medicine. 20(4). 567–572.
17.
Wang, Qing‐Dong, et al.. (1995). Beneficial Effects of H290/51, a New Lipid Peroxidation Inhibitor, on Functional Recovery After Ischemia and Reperfusion in Isolated Cold-Arrested Rat Hearts. Journal of Cardiovascular Pharmacology. 25(6). 924–929.
18.
Hatori, Nobuo, Yoshiyuki Haga, Per‐Ove Sjöquist, Margareta Nordlander, & Lars Rydén. (1993). Coronary Venous Retroinfusion of Felodipine Reduces Myocardial Necrosis After Coronary Occlusion and Reperfusion. Journal of Cardiovascular Pharmacology. 22(1). 160–166.
19.
Rydén, Lars, Hiroyuki Tadokoro, Per‐Ove Sjöquist, et al.. (1991). Pharmacokinetic analysis of coronary venous retroinfusion: A comparison with anterograde coronary artery drug administration using metoprolol as a tracer. Journal of the American College of Cardiology. 18(2). 603–612.
20.
Nerme, Viveca, et al.. (1990). The β1 and β2‐adrenoceptor affinity and β1‐blocking potency of S‐ and R‐metoprolol. British Journal of Pharmacology. 99(3). 592–596.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Zoltán Szilvássy Breakdown of academic impact, for papers by Barbara Huisamen Breakdown of academic impact, for papers by David M. Ansley Breakdown of academic impact, for papers by Abdullah Tuncay Demiryürek Breakdown of academic impact, for papers by Akiyoshi Hara Breakdown of academic impact, for papers by Han‐Wu Deng Breakdown of academic impact, for papers by Reza Badalzadeh Breakdown of academic impact, for papers by Cherry L. Wainwright Breakdown of academic impact, for papers by Paul M. Kerr Breakdown of academic impact, for papers by Keisuke Satoh